Innovation & Research

Last Publications

Delafloxacin: Activity against Fastidious Organisms Tested by EUCAST vs CLSI Methodology

CD205-Shuttle Study: a first in human trial of Men1309/OBT076 an ADC targeting CD205 in solid tumor and NHL

Translational model-based approach to the dose-range selection of an antibody-drug conjugate entering Phase I.

The role of MEN1611, a class I PI3-kinase (PI3K) inhibitor, in reprogramming the pro-tumoral inflammatory environment.

MEN1611, a novel a-selective PI3K inhibitor in solid tumors

Search Menarini in the world


Etiam commodo dui eget wisi. Donec iaculis gravida nulla. Donec quis nibh at felis congue commodo. Etiam bibendum elit eget erat.


Drug development is a challenging process, and success relies on the integration of innovative scientific discoveries with the necessary capabilities and resources to transform them into effective healthcare solutions.

Read More